Complete Genomics Adds CNV Analysis to Cancer Sequencing

December 9, 2010 | Complete Genomics is amping up its efforts to sequence cancer genomes. As an addition to its $10,000 sequencing service, the company plans to run basic computational analysis for all the copy number variations, and structural variations in tumors at no extra cost. Xconomy